Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II

European Heart Journal

Volumn 37, Issue 33, 2016, Pages 2591-2601

  Crespo Leiro, Maria G ^a   Stypmann, Jörg ^b   Schulz, Uwe ^c   Zuckermann, Andreas ^d   Mohacsi, Paul ^e   Bara, Christoph ^f   Ross, Heather ^g   Parameshwar, Jayan ^h   Zakliczyński, Michal ⁱ   Fiocchi, Roberto ^j   Hoefer, Daniel ^k   Colvin, Monica ^l   Deng, Mario C ^m   Leprince, Pascal ⁿ   Elashoff, Barbara ^o   Yee, James P ^o   Vanhaecke, Johan ^p  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF BERN   (Switzerland)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g TORONTO GENERAL HOSPITAL   (Canada)

^h PAPWORTH HOSPITAL   (United Kingdom)

ⁱ MEDICAL UNIVERSITY OF SILESIA   (Poland)

^j OSPEDALI RIUNITI   (Italy)

^k INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^l UNIVERSITY OF MINNESOTA   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o CareDx   (United States)

^p UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

AlloMap; Heart transplant; Molecular diagnostics; Organ rejection; Rejection surveillance; Tests

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; TRANSCRIPTOME;

ACUTE GRAFT REJECTION; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; DISEASE SURVEILLANCE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENE EXPRESSION PROFILING; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; BIOPSY; CARDIAC MUSCLE; GRAFT REJECTION; MICROARRAY ANALYSIS;

BIOPSY; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MICROARRAY ANALYSIS; MYOCARDIUM; TRANSCRIPTOME;

EID: 84987653147     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv682     Document Type: Article

References (24)

1. Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Walther D, Lal PG, Rosenberg S, Hunt S, CARGO Investigators. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006;6:150-160.
2. Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC, Working Group on Molecular Testing in Cardiac Transplantation. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant 2006;25:1389-1395.
3. Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Elashoff B, Baron H, Yee J, Valantine HA, IMAGE Study Group. Gene expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010;362: 1890-1900.
4. Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, Zuckermann A, Hunt S, Burch M, Bhat G, Canter C, Chinnock R, Crespo- Leiro M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, Keogh A, Lewis C, O'Connell J, Rogers J, Ross H, Russell S, Vanhaecke J, International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29:914-956.
5. Hresko A, Haga SB. Insurance coverage for personalized medicine. J Pers Med 2012; 2:201-216.
6. CareDx (XDx) GEP Laboratory Services Guide, LQ10004R2. http://www. allomap.com/wp-content/uploads/2014/04/XDx-LabServicesGuideFINAL 3electronicversion.pdf (02 August 2015).
7. Austin BA, Arnold PJ, Kao A. The impact of time post cardiac transplant on gene expression profile scores, an analysis of 32, 043 Tests. J Cardiovasc Dis Diag 2013; 1:114.
8. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Transplant 1990;9:587-593.
9. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-1720.
10. Crespo-Leiro MG, Zuckermann A, Bara C, Mohacsi P, Schulz U, Boyle A, Ross HJ, Parameshwar J, Zakliczyński M, Fiocchi R, Stypmann J, Hoefer D, Lehmkuhl H, Deng MC, Leprince P, Berry G, Marboe CC, Stewart S, Tazelaar HD, Baron HM, Coleman IC, Vanhaecke J. Concordance among pathologists in the second cardiac allograft rejection gene expression observational study (CARGO II). Transplantation 2012;94:1172-1177.
11. Marboe CC, Billingham M, Eisen H, Deng MC, Baron H, Mehra M, Hunt S, Wohlgemuth J, Mahmood I, Prentice J, Berry G. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 2005;24(7 Suppl): 219-S226.
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
13. Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 2011;123:551-565.
14. Obuchowski NA. Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary. Acad Radiol 2005;12:1198-1204.
15. Emir B, Wieand S, Su JQ, Cha S. Analysis of repeated markers used to predict progression of cancer. Stat Med 1998;17:2563-2578.
16. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI, International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 2012;31:1052-1064.
17. Kubo SH, Naftel DC, Mills RM Jr, O'Donnell J, Rodeheffer RJ, Cintron GB, Kenzora JL, Bourge RC, Kirklin JK. Risk factors for late recurring rejection after heart transplantation: a multiinstitutional, multivariable analysis. J Heart Lung Transplant 1995;14:409-418.
18. Hamour IM, Burke MM, Bell AD, Panicker MG, Banerjee R, Banner NR. Limited utility of endomyocardial biopsy in the first year after heart transplantation. Transplantation 2008;85:969-974.
19. Bernstein D, Williams GE, Eisen H, Mital S, Wohlgemuth JG, Klingler TM, Fang KC, Deng MC, Kobashigawa J. Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients. J Heart Lung Transplant 2007;26:1270-1280.
20. Reeve J, Sellarés J, Mengel M, Sis B, Skene A, Hidalgo L, de Freitas DG, Famulski KS, Halloran PF. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 2013;13:645-655.
21. Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am J Transplant 2013;13:2325-2326.
22. Deng MC, Elashoff B, Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Shahzad K, Hiller D, Yee J, Valantine HA, IMAGE Study Group. Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients. Transplantation 2014;97:708-714.
23. Crespo-Leiro MG, Stypmann J, Zuckermann A, Bara C, Ross H, Parameshwar J, Zakliczynski M, Fiocchi R, Hoefer D, Hiemann N, Leprince P, Deng MC, Hiller D, Yee JP, Vanhaecke J. Utility of gene expression profiling test (GEP) score instability to predict future clinical outcomes in heart transplant: results from the CARGO 2 European-based multicenter trial. J Heart Lung Transplant 2013;32: S113-S114.
24. Kobashigawa J, Patel J, Azarbal B, Kittleson M, Chang D, Czer L, Daun T, Luu M, Trento A, Cheng R, Esmailian F. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial. Circ Heart Fail 2015;8:557-564.